Adjuvant therapy for malignant pleural mesothelioma.

S. M. Keller

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Patients with malignant pleural mesothelioma appear to have gained little benefit from even the most intensive multimodality therapy. Although the reported median survival of patients who undergo some surgical procedure as part of their therapy appears to be superior to that of those patients treated in a nonoperative fashion, the lack of a randomized trial renders these data suspect. New approaches, perhaps consisting of biologic response modifiers, more effective chemotherapy, and innovative methods that achieve improved local disease control, are needed.

Original languageEnglish (US)
Pages (from-to)127-135
Number of pages9
JournalChest surgery clinics of North America
Issue number1
StatePublished - Feb 1994

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Adjuvant therapy for malignant pleural mesothelioma.'. Together they form a unique fingerprint.

Cite this